(Q36608587)

15 August 2017

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer (English)

1 reference

15 August 2017

1 reference

19

Edouard J Trabulsi

1 reference

15 August 2017

2

Roland L Dunbrack

1 reference

15 August 2017

8

Katherine Alpaugh

1 reference

15 August 2017

Elizabeth R Plimack

1

1 reference

15 August 2017

Timothy A Brennan

3

1 reference

15 August 2017

Mark D Andrake

4

1 reference

15 August 2017

Yan Zhou

5

1 reference

15 August 2017

Ilya G Serebriiskii

6

1 reference

15 August 2017

Michael Slifker

7

1 reference

15 August 2017

Essel Dulaimi

9

1 reference

15 August 2017

Norma Palma

10

1 reference

15 August 2017

Jean Hoffman-Censits

11

1 reference

15 August 2017

Marijo Bilusic

12

1 reference

15 August 2017

Yu-Ning Wong

13

1 reference

15 August 2017

Alexander Kutikov

14

1 reference

15 August 2017

Rosalia Viterbo

15

1 reference

15 August 2017

Richard E Greenberg

16

1 reference

15 August 2017

David Y T Chen

17

1 reference

15 August 2017

Costas D Lallas

18

1 reference

15 August 2017

Roman Yelensky

20

1 reference

15 August 2017

David J McConkey

21

1 reference

15 August 2017

Vincent A Miller

22

1 reference

15 August 2017

Erica A Golemis

23

1 reference

15 August 2017

Eric A Ross

24

1 reference

15 August 2017

language of work or name

English

0 references

publication date

31 July 2015

1 reference

15 August 2017

1 reference

15 August 2017

68

1 reference

15 August 2017

959-967

1 reference

15 August 2017

6

1 reference

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Comprehensive molecular characterization of urothelial bladder carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Mutational landscape and significance across 12 major cancer types

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Molecular mechanisms of cisplatin resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

The DNA Damage Response: Making It Safe to Play with Knives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Platinum resistance: the role of DNA repair pathways

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

The Fanconi anaemia/BRCA pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

RB-dependent S-phase response to DNA damage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Prediction of phenotypes of missense mutations in human proteins from biological assemblies

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4764095

Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26238431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26238431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26238431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.EURURO.2015.07.009

1 reference

15 August 2017

1 reference

15 August 2017

1 reference